Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C63425> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- NCIT_C63425 IAO_0000115 "A regimen consisting of cyclophosphamide and doxorubicin followed by paclitaxel and trastuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer." @default.
- NCIT_C63425 NCIT_NHC0 "C63425" @default.
- NCIT_C63425 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C63425 NCIT_P108 "AC-T-T Regimen" @default.
- NCIT_C63425 NCIT_P207 "C1879499" @default.
- NCIT_C63425 NCIT_P302 "HER2 positive: Neoadjuvant or Adjuvant Breast Cancer" @default.
- NCIT_C63425 NCIT_P325 "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin)." @default.
- NCIT_C63425 NCIT_P366 "AC-T-T_Regimen" @default.
- NCIT_C63425 NCIT_P98 "Source: NCCN Guidelines 2017" @default.
- NCIT_C63425 NCIT_R123 NCIT_C129821 @default.
- NCIT_C63425 NCIT_R123 NCIT_C129822 @default.
- NCIT_C63425 NCIT_R123 NCIT_C129824 @default.
- NCIT_C63425 NCIT_R123 NCIT_C129825 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1411 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1490 @default.
- NCIT_C63425 NCIT_R123 NCIT_C155711 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1590 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1594 @default.
- NCIT_C63425 NCIT_R123 NCIT_C163758 @default.
- NCIT_C63425 NCIT_R123 NCIT_C163760 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1647 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1748 @default.
- NCIT_C63425 NCIT_R123 NCIT_C186664 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1908 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1909 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1913 @default.
- NCIT_C63425 NCIT_R123 NCIT_C1968 @default.
- NCIT_C63425 NCIT_R123 NCIT_C20401 @default.
- NCIT_C63425 NCIT_R123 NCIT_C2114 @default.
- NCIT_C63425 NCIT_R123 NCIT_C2115 @default.
- NCIT_C63425 NCIT_R123 NCIT_C2161 @default.
- NCIT_C63425 NCIT_R123 NCIT_C2189 @default.
- NCIT_C63425 NCIT_R123 NCIT_C259 @default.
- NCIT_C63425 NCIT_R123 NCIT_C25974 @default.
- NCIT_C63425 NCIT_R123 NCIT_C273 @default.
- NCIT_C63425 NCIT_R123 NCIT_C274 @default.
- NCIT_C63425 NCIT_R123 NCIT_C2842 @default.
- NCIT_C63425 NCIT_R123 NCIT_C307 @default.
- NCIT_C63425 NCIT_R123 NCIT_C308 @default.
- NCIT_C63425 NCIT_R123 NCIT_C405 @default.
- NCIT_C63425 NCIT_R123 NCIT_C456 @default.
- NCIT_C63425 NCIT_R123 NCIT_C471 @default.
- NCIT_C63425 NCIT_R123 NCIT_C552 @default.
- NCIT_C63425 NCIT_R123 NCIT_C574 @default.
- NCIT_C63425 NCIT_R123 NCIT_C616 @default.
- NCIT_C63425 NCIT_R123 NCIT_C67437 @default.
- NCIT_C63425 NCIT_R123 NCIT_C67502 @default.
- NCIT_C63425 NCIT_R123 NCIT_C697 @default.
- NCIT_C63425 NCIT_R123 NCIT_C718 @default.
- NCIT_C63425 NCIT_R123 NCIT_C860 @default.
- NCIT_C63425 NCIT_R172 NCIT_C26709 @default.
- NCIT_C63425 NCIT_R172 NCIT_C27551 @default.
- NCIT_C63425 NCIT_R172 NCIT_C2852 @default.
- NCIT_C63425 NCIT_R172 NCIT_C2910 @default.
- NCIT_C63425 NCIT_R172 NCIT_C2916 @default.
- NCIT_C63425 NCIT_R172 NCIT_C2991 @default.
- NCIT_C63425 NCIT_R172 NCIT_C3262 @default.
- NCIT_C63425 NCIT_R172 NCIT_C3263 @default.
- NCIT_C63425 NCIT_R172 NCIT_C3709 @default.
- NCIT_C63425 NCIT_R172 NCIT_C4741 @default.
- NCIT_C63425 NCIT_R172 NCIT_C4872 @default.
- NCIT_C63425 NCIT_R172 NCIT_C5214 @default.
- NCIT_C63425 NCIT_R172 NCIT_C53553 @default.
- NCIT_C63425 NCIT_R172 NCIT_C53556 @default.
- NCIT_C63425 NCIT_R172 NCIT_C7057 @default.
- NCIT_C63425 NCIT_R172 NCIT_C7062 @default.
- NCIT_C63425 NCIT_R172 NCIT_C7132 @default.
- NCIT_C63425 NCIT_R172 NCIT_C9305 @default.
- NCIT_C63425 NCIT_R172 NCIT_C9335 @default.
- NCIT_C63425 normalizedInformationContent "100" @default.
- NCIT_C63425 referenceCount "1" @default.
- NCIT_C63425 hasExactSynonym "AC Followed by Paclitaxel + Trastuzumab" @default.
- NCIT_C63425 hasExactSynonym "AC Followed by Paclitaxel/Trastuzumab Regimen" @default.
- NCIT_C63425 hasExactSynonym "AC-T-T Regimen" @default.
- NCIT_C63425 hasExactSynonym "AC-T-T regimen" @default.
- NCIT_C63425 hasExactSynonym "AC-T-T" @default.
- NCIT_C63425 hasExactSynonym "AC-TH Regimen" @default.
- NCIT_C63425 hasExactSynonym "AC-TH regimen" @default.
- NCIT_C63425 hasExactSynonym "Doxorubicin/Cyclophosphamide Followed by Paclitaxel + Trastuzumab" @default.
- NCIT_C63425 hasExactSynonym "Sequential AC/Taxol-Trastuzumab Regimen" @default.
- NCIT_C63425 hasExactSynonym "sequential AC/Taxol-Trastuzumab regimen" @default.
- NCIT_C63425 inSubset NCIT_C160950 @default.
- NCIT_C63425 inSubset NCIT_C160952 @default.
- NCIT_C63425 type Class @default.
- NCIT_C63425 isDefinedBy ncit.owl @default.
- NCIT_C63425 label "AC-T-T Regimen" @default.
- NCIT_C63425 subClassOf B0e3295ddbb0411b82b73b222bd7c3ed4 @default.
- NCIT_C63425 subClassOf B0f2fe7f4210dc826d139490053226411 @default.
- NCIT_C63425 subClassOf B2b52d176c6af5a1e1550c53c074c52f2 @default.
- NCIT_C63425 subClassOf B2c78282637478617fdecf25ec7d35c0e @default.
- NCIT_C63425 subClassOf B7749440f33945dc963045fed38499953 @default.
- NCIT_C63425 subClassOf B7bff618a7d7e048247bfe7442cc95489 @default.
- NCIT_C63425 subClassOf B8094dfd267832388e5d093ddd23a54ce @default.
- NCIT_C63425 subClassOf Bd87a329f31c7f1a02be43a89b5421e12 @default.
- NCIT_C63425 subClassOf Be8594eb51015967586ca2aa5810d4180 @default.
- NCIT_C63425 subClassOf Bf74c5cb176482bbe2ba5da19803f29f6 @default.
- NCIT_C63425 subClassOf NCIT_C12218 @default.
- NCIT_C63425 subClassOf NCIT_C62634 @default.
- NCIT_C63425 subClassOf NCIT_C63358 @default.
- NCIT_C63425 subClassOf NCIT_C63425 @default.